2026 Media Kit
Journal of Immunotherapy
Format
Print and Online
Website
http://www.immunotherapy-journal.com/
Specialty
Oncology; Allergy & Immunology
Audience
Immunotherapy and biological therapy physicians and researchers
Content Focus
Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. Journal of Immunotherapy contains full-length articles, review articles, and short communications.
Impact Factor
2.9
Impact Factor Ranking
153/326 in Oncology category
99/183 in Immunology category
93/195 in Medicine, Research & Experimental category
Editor-in-Chief
Steven A. Rosenberg, MD, PhD
Frequency
9 issues per year
Advertising Guidelines
Subject to approval by Editor. New copy must be received by the Publisher two weeks before closing date.
